newsfilter
← Latest News
GlobeNewswire·

InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor

VANCOUVER, British Columbia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM), a leader in the pharmaceutical research, development and manufacturing of rare